Harvard Bioscience (HBIO) EBIT Margin Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 7,391.00 |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 722.00 |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1,105.00 |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 800.00 |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -368.00 |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -1,384.00 |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -1,411.00 |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -51.00 |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | -1,149.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,149.00 |
| Dec 31, 2025 | 881.00 |
| Sep 30, 2025 | 1,493.00 |
| Jun 30, 2025 | -1,769.00 |
| Mar 31, 2025 | -20,478.00 |
| Dec 31, 2024 | -510.00 |
| Sep 30, 2024 | -1,038.00 |
| Jun 30, 2024 | -916.00 |
| Mar 31, 2024 | -841.00 |
| Dec 31, 2023 | -789.00 |
| Sep 30, 2023 | -444.00 |
| Jun 30, 2023 | 38.00 |
| Mar 31, 2023 | 1,960.00 |
| Dec 31, 2022 | -688.00 |
| Sep 30, 2022 | -900.00 |
| Jun 30, 2022 | 1,292.00 |
| Mar 31, 2022 | -2,290.00 |
| Dec 31, 2021 | -1.00 |
| Sep 30, 2021 | -126.00 |
| Jun 30, 2021 | 141.00 |